Giudice, Linda C

No ORCID on file · 21 papers in corpus · active 2015-2025

Study types

  • article 15
  • dataset 3
  • other 3

Condition tags

  • endometriosis 21
  • infertility 4
other 2025
·doi:10.17605/osf.io/axwz9

Guidance on standards of care, particularly incorporating region-specific needs, is foundational to high-quality healthcare. The availability of region-specific guidance on endometriosis care has not been documented, especially in low- and …

dataset 2022
·doi:10.6084/m9.figshare.19602462.v1

Additional file 1: Table S1. Samples used in the study. Endo: endometriosis; PE: proliferative; SE: secretory: MSE: mid secretory, LSE: late secretory; N/A: not applicable.

dataset 2022
·doi:10.6084/m9.figshare.19602465.v1

Additional file 2: Table S2. CyTOF panels used in the study. Left: broad panel, right: focused panel.

article 2022
·doi:10.6084/m9.figshare.19602468.v1

Additional file 3: Fig. S1. Manual gating strategy for the focused panel. The figure shows an example of the dot plots obtained using FlowJo in endometrial cells.

article 2022
·doi:10.6084/m9.figshare.19602468

Additional file 3: Fig. S1. Manual gating strategy for the focused panel. The figure shows an example of the dot plots obtained using FlowJo in endometrial cells.

article 2022
·doi:10.6084/m9.figshare.19602471.v1

Additional file 4: Fig. S2. Endometrial sampling methods. A) The figure shows UMAPs of the two methods used for endometrial tissue collection, biopsy (red) and hysterectomy (blue). The left panel shows a UMAP with the overlap between the tw…

article 2022
·doi:10.6084/m9.figshare.19602471

Additional file 4: Fig. S2. Endometrial sampling methods. A) The figure shows UMAPs of the two methods used for endometrial tissue collection, biopsy (red) and hysterectomy (blue). The left panel shows a UMAP with the overlap between the tw…

article 2022
·doi:10.6084/m9.figshare.19602474

Additional file 5: Fig. S3. Batch effects derived from different runs. The figure shows UMAPs representing the distribution of the cells from the runs in the CyTOF instrument for both endometrium (top panel) and PBMCs (bottom panel). The fi…

article 2022
·doi:10.6084/m9.figshare.19602474.v1

Additional file 5: Fig. S3. Batch effects derived from different runs. The figure shows UMAPs representing the distribution of the cells from the runs in the CyTOF instrument for both endometrium (top panel) and PBMCs (bottom panel). The fi…

article 2022
·doi:10.6084/m9.figshare.19602477

Additional file 6: Fig. S4. Proportion of endometrial immune populations identified by using the broad panel. The figure shows the proportion of each population in the ring graphs and the percentage of each population is also shown in each …

article 2022
·doi:10.6084/m9.figshare.19602477.v1

Additional file 6: Fig. S4. Proportion of endometrial immune populations identified by using the broad panel. The figure shows the proportion of each population in the ring graphs and the percentage of each population is also shown in each …

article 2022
·doi:10.6084/m9.figshare.19602480.v1

Additional file 7: Fig. S5. Fluctuation of all endometrial immune populations identified in the broad panel. A) Differences in abundance of populations throughout the menstrual cycle in control samples. B) Differences in abundance of popula…

article 2022
·doi:10.6084/m9.figshare.19602480

Additional file 7: Fig. S5. Fluctuation of all endometrial immune populations identified in the broad panel. A) Differences in abundance of populations throughout the menstrual cycle in control samples. B) Differences in abundance of popula…

article 2022
·doi:10.6084/m9.figshare.19602486.v1

Additional file 8: Fig. S6. Fluctuation of all endometrial immune populations identified in the focused panel. A) Differences in abundance of populations throughout the menstrual cycle in control samples. B) Differences in abundance of popu…

article 2022
·doi:10.6084/m9.figshare.19602486

Additional file 8: Fig. S6. Fluctuation of all endometrial immune populations identified in the focused panel. A) Differences in abundance of populations throughout the menstrual cycle in control samples. B) Differences in abundance of popu…

dataset 2022
·doi:10.6084/m9.figshare.19602489.v1

Additional file 9: Table S3. Expression of the significant markers between endometriosis and controls in all cell types in endometriosis versus controls from the focused panel. Significant values are highlighted in grey. Endo: endometriosis…

other 2022
·doi:10.6084/m9.figshare.c.5949336

Abstract Background Endometriosis is a chronic, estrogen-dependent disorder where inflammation contributes to disease-associated symptoms of pelvic pain and infertility. Immune dysfunction includes insufficient immune lesion clearance, a pr…

other 2022
·doi:10.6084/m9.figshare.c.5949336.v1

Abstract Background Endometriosis is a chronic, estrogen-dependent disorder where inflammation contributes to disease-associated symptoms of pelvic pain and infertility. Immune dysfunction includes insufficient immune lesion clearance, a pr…

article 2020

Programmed cellular responses to cycling ovarian-derived steroid hormones are central to normal endometrial function. Abnormalities therein, as in the estrogen-dependent, progesterone-"resistant" disorder, endometriosis, predispose to infer…

article 2017

The 3rd International Consensus Workshop on Research Priorities in Endometriosis was held in São Paulo on May 4, 2014, following the 12th World Congress on Endometriosis. The workshop was attended by 60 participants from 19 countries and wa…

article 2015

Krüppel-like Factor (KLF) 13 and the closely related KLF9 are members of the Sp/KLF family of transcription factors that have collectively emerged as essential regulators of tissue development, differentiation, proliferation, and programmed…